Humoral Hypercalcemia of Malignancy

DBCOND0039468Endocrine System DiseasesNeoplasms

Humoral Hypercalcemia of Malignancy is the indication for 12 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as
Hypercalcaemia of malignancy · Hypercalcemia of Malignancy · cancer related hypercalcemia · cancer-related hypercalcemia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0562690SNOMED CT47709007MedDRA10020584UMLSC0149911

What you can answer from here — as of October 04, 2026

12Indicated drugsWith each drug's targets and mechanism
Listed above
12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Humoral Hypercalcemia of Malignancy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In